Trial NCT03059303

View at ClinicalTrials.gov 
Org. Study IDs: CR108273
Secondary IDs: 64294178HPC1018

Last trial update was posted on 2017-12-22

MeSH Interventions

Dexlansoprazole Lansoprazole Odalasvir Omeprazole Simeprevir

MeSH Conditions


Other Conditions

Healthy

Stopping Reasons

Decision to discontinue development of investigational Hep C treatment regimen JNJ-4178: 3 direct acting antivirals - AL-335, ODV & SMV.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID